The Research Accelerating RUNX1 Exploration Grant: Up to $250,000 over 2 years
The Research Accelerating RUNX1 Exploration (RARE) Grant is a two-year award designed to fund research that will lead to the development of therapies for patients with RUNX1-FPD that will either intercept the transition from a precancer state (clonal hematopoiesis) to MDS/AML or prevention of cancer (before clonal hematopoiesis).
The RUNX1 Early Career Investigator Grant: Up to $180,000 over three years
The purpose of the RUNX1 Early Career Investigator Grant is to promote the establishment of a new generation of translational and clinical researchers interested in tackling inherited hematologic malignancy predisposition disorders with a focus on RUNX1-familial platelet disorder. We believe that providing capital to early career investigators not only injects funding into where it is needed most, but also cultivates a new cohort of investigators who will be invested in an area of research that historically has had limited attention. The Program is viewed as a long-term endeavor of collaboration and data sharing. We are especially interested in innovative and cross-disciplinary approaches to developing effective therapies.
The 2027 RUNX1 Early Career Investigator Grant is currently being offered. To apply, please visit the Applicant page.